JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 103 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $488,900 | +61552.0% | 264,270 | -63.0% | 0.00% | – |
| Q4 2022 | $793 | -100.0% | 715,037 | -29.0% | 0.00% | -100.0% |
| Q3 2022 | $2,355,000 | -34.6% | 1,006,646 | -15.3% | 0.00% | 0.0% |
| Q2 2022 | $3,599,000 | -55.1% | 1,187,801 | +0.7% | 0.00% | -50.0% |
| Q1 2022 | $8,012,000 | -14.2% | 1,179,953 | +5.5% | 0.00% | -33.3% |
| Q4 2021 | $9,341,000 | +20.0% | 1,118,701 | +6.8% | 0.00% | 0.0% |
| Q3 2021 | $7,783,000 | -6.7% | 1,047,545 | -14.6% | 0.00% | 0.0% |
| Q2 2021 | $8,345,000 | -23.4% | 1,227,280 | +15.7% | 0.00% | -25.0% |
| Q1 2021 | $10,890,000 | +32.2% | 1,060,431 | -9.9% | 0.00% | +33.3% |
| Q4 2020 | $8,239,000 | -15.1% | 1,177,073 | -1.0% | 0.00% | -25.0% |
| Q3 2020 | $9,702,000 | +22.7% | 1,188,967 | +3.8% | 0.00% | +33.3% |
| Q2 2020 | $7,904,000 | +54.9% | 1,145,370 | +6.6% | 0.00% | 0.0% |
| Q1 2020 | $5,103,000 | -31.6% | 1,074,216 | +25.7% | 0.00% | 0.0% |
| Q4 2019 | $7,460,000 | +175.6% | 854,606 | +5.1% | 0.00% | +200.0% |
| Q3 2019 | $2,707,000 | -29.6% | 812,828 | +4.6% | 0.00% | 0.0% |
| Q2 2019 | $3,847,000 | -3.9% | 777,264 | +20.3% | 0.00% | -50.0% |
| Q1 2019 | $4,005,000 | +160.1% | 646,000 | +41.4% | 0.00% | +100.0% |
| Q4 2018 | $1,540,000 | -45.4% | 456,865 | +5.3% | 0.00% | 0.0% |
| Q3 2018 | $2,819,000 | +16.9% | 433,712 | +37.8% | 0.00% | 0.0% |
| Q2 2018 | $2,412,000 | -2.0% | 314,831 | +186.0% | 0.00% | 0.0% |
| Q1 2018 | $2,460,000 | – | 110,069 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
| TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
| Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
| PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
| Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
| Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
| PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
| Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |